What Happened?
Philadelphia, PA-based GlaxoSmithKline Appointed John Muller as VP Emerging Technology and Architecture RandD
About the Company
We are a science-led global healthcare company that researches and develops a broad range of innovative products in three primary areas of pharmaceuticals, vaccines and consumer healthcare. As one of the few healthcare companies researching both medicines and vaccines for the World Health Organization`s three priority diseases – HIV/AIDS, tuberculosis and malaria, we are very proud to have developed some of the leading global medicines in these fields. Our product portfolio also includes a range of consumer brands, many of which are household names around the world, including Sensodyne, Aquafresh, Horlicks, Panadol and Tums.
About the Person
John Muller is VP Emerging Technology and Architecture RandD at GlaxoSmithKline. Previously, John held various senior IT leadership roles in the industry.
Info Source
News
Short Profile